Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss
Crossref DOI link: https://doi.org/10.1186/1471-2334-14-542
Published Online: 2014-10-09
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Modongo, Chawangwa
Sobota, Rafal S
Kesenogile, Boikobo
Ncube, Ronald
Sirugo, Giorgio
Williams, Scott M
Zetola, Nicola M
License valid from 2014-10-09
Article History
Received: 3 February 2014
Accepted: 30 September 2014
First Online: 9 October 2014